secwatch.observer — SEC 8-K summary
======================================

Issuer:     Avalo Therapeutics, Inc. (AVTX)
CIK:        0001534120
Form:       8-K
Filed at:   2023-06-02T23:59:59+00:00
Accession:  0001628280-23-020611
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avalo Therapeutics exchanges 1.3M shares for pre-funded warrants with Venrock affiliates
--------------------------------------------------------------------------------

- Exchanged 1,300,000 shares of common stock for pre-funded warrants exercisable for 1,300,000 shares at $0.001 per share.
- Warrants include a 9.99% beneficial ownership limitation, adjustable to 19.99% with 61 days' notice.
- Venrock Healthcare Capital Partners affiliates (Venrock EG, Venrock III, VHCP Co-Investment) are the exchanging stockholders.
- No new cash raised; transaction exempt from registration under Section 3(a)(9) of Securities Act.
- Shares exchanged represent all 1.3M shares held by Venrock entities; warrants issued immediately.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534120/000162828023020611/0001628280-23-020611-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534120/000162828023020611/avtx-20230531.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-020611

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer